News & Analysis as of

Startups Biotechnology Venture Capital

Wilson Sonsini Goodrich & Rosati

[Event] Biotech Summit 2024 - October 9th - 10th, Boston, MA

Wilson Sonsini’s inaugural Biotech Summit will address topics of critical importance to Biotech and Biopharmaceutical companies, including early and late-stage venture financing, partnering strategies, current and future AI...more

AEON Law

EU Study Shows Startups with IP 1000% More Likely to Be Funded

AEON Law on

The European Patent Office (EPO) and the European Union Intellectual Property Office (EUIPO) have released a 61-page study showing that EU startups that secure intellectual property (IP) rights protection are 10.2 times more...more

Mintz

Client Corner: Meet Biotech Executive John Edwards

Mintz on

Our Client Corner: Perspectives from Founders, Financiers, and Friends podcast series hosted by Mintz Member Joshua Fox explores the dynamics of starting and running a business, investing in a business, and helping to support...more

Foley & Lardner LLP

Navigating the AI Frontier: Legal and Operational Insights Into Generative AI

Foley & Lardner LLP on

In our ever-changing technological environment, artificial intelligence (AI) is beginning to exert its influence on numerous sectors, revolutionizing our approach to work. As businesses and organizations worldwide adopt...more

Mintz - Venture Capital & Emerging Companies...

Five Ways To Target Success As A Startup

Turning innovation into a successful business can be daunting. In a panel discussion at the 2023 BIO International Convention, Mintz’s Josh Fox, who is a Member in our Chambers-ranked Life Sciences practice, alongside...more

Rothwell, Figg, Ernst & Manbeck, P.C.

Ceribell Announces Completion of $53 Million Series C Financing for Portable EEG that can Diagnose Seizures in Minutes

On April 29, 2021, Mountain View, California-based startup Ceribell, Inc. announced the completion of a $53 million Series C financing, co-led by Longitude Capital and The Rise Fund. Other new investors include RA Capital...more

Rothwell, Figg, Ernst & Manbeck, P.C.

Capsida Biotherapeutics Debuts with $140 Million of Capital for its AAV Gene Therapies

Capsida Biotherapeutics Inc.—a  Thousand Oaks, CA-based emerging biotechnology company—recently emerged from stealth mode with $ 140 million in start-up capital. Capsida secured a $50 million Series A commitment from Versant...more

WilmerHale

In Case You Missed It: Launch Links - March 2019 #3

WilmerHale on

Some interesting links we found across the web this week: When and Why Diversity Improves Your Board’s Performance Diversity for diversity’s sake likely will not have a significant impact on your market performance....more

WilmerHale

In Case You Missed It: Launch Links - February 2019 #4

WilmerHale on

Some interesting links we found across the web this week: 7 Tips for Biotech Companies Seeking Capital in a Volatile Market - Biotech companies garnered over a whopping $6.3 billion in IPO revenue in 2018. As companies...more

WilmerHale

In Case You Missed It: Launch Links - July, 2018 #3

WilmerHale on

Some interesting links we found across the web this week: The Tech Investment Wave has Reached Latin America - The momentum for VC funding seems to be growing in Latin America, where big banks dominate the market and...more

McDonnell Boehnen Hulbert & Berghoff LLP

Second Quarter Venture Funding Increases 20% from First Quarter

Earlier this year, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the second quarter of...more

WilmerHale

In Case You Missed It: Launch Links - February 2016 #4

WilmerHale on

Some interesting links we found across the web this week: Has this year's startup funding slowdown been overblown? Debate continues over the perceived downturn in the market for venture capital, as a new...more

WilmerHale

In Case You Missed It: Launch Links - Week of January 31, 2016

WilmerHale on

Some interesting links we found across the web this week: The State of Venture Capital - How much VC money is out there, and where is it coming from? Click through to the full presentation for a detailed...more

McGuireWoods LLP

Venture Capital Coast to Coast – June 2015

McGuireWoods LLP on

As we reported in January 2015, 2014 was a banner year for venture capital on all fronts, from fundraising, to investment and exits – save, however, for the small drop in the number of deals versus the largest aggregate...more

McDonnell Boehnen Hulbert & Berghoff LLP

Venture Funding Reaches Highest Level in More Than a Decade

Last month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for 2014. The report, which is...more

Knobbe Martens

California Healthcare Institute Releases 2015 California Biomedical Industry Report

Knobbe Martens on

The California Healthcare Institute and PricewaterhouseCoopers, LLP have released their 2015 California Biomedical Industry Report describing industry trends through 2014. The CHI report highlights the continued strength of...more

McDonnell Boehnen Hulbert & Berghoff LLP

Annual Venture Funding Drops for First Time in Three Years

Last month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for 2012. The report, which is...more

Foley Hoag LLP

Follow-on Biologics and Patent Reform: Will They Discourage Venture Capital Investment in the Biotechnology Industry?

Foley Hoag LLP on

According to a study by PricewaterhouseCoopers and the National Venture Capital Association, venture capital (VC) investing hit a five-year high in 2006, with $25.5 billion invested. Notably, the Life Sciences sector, which...more

18 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide